Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hardy

Showing results (531-540 of 541) with videos related to

Pageof 55
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 31, 2009
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonistL Rihakova, C Quiniou, F F Hamdan, et al.
International Journal of Molecular Sciences|March 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRnSandra Wymann, Rodrigo A V Morales, Wei Hong Toh, et al.
Cell Reports|July 22, 2014
Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibodySophie E Broughton, Timothy R Hercus, Matthew P Hardy, et al.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Nature Chemical Biology|October 30, 2012
Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humansWei Ge, Alexander Wolf, Tianshu Feng, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 10, 2021
Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trialC B Okeke Ogwulu, E V Williams, J J Chu, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 17, 2025
Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013R S Gill, S Apte, S Majumdar, et al.
Pageof 55

Showing results (531-540 of 541) with videos related to

Sort By:
Pageof 55
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 31, 2009
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonistL Rihakova, C Quiniou, F F Hamdan, et al.
International Journal of Molecular Sciences|March 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRnSandra Wymann, Rodrigo A V Morales, Wei Hong Toh, et al.
Cell Reports|July 22, 2014
Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibodySophie E Broughton, Timothy R Hercus, Matthew P Hardy, et al.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Nature Chemical Biology|October 30, 2012
Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humansWei Ge, Alexander Wolf, Tianshu Feng, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 10, 2021
Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trialC B Okeke Ogwulu, E V Williams, J J Chu, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 17, 2025
Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013R S Gill, S Apte, S Majumdar, et al.
Pageof 55